Oregon Capital Scan: a Developing Ecosystem by Niels Zellers
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
2017 Flywheel Investment Conference’S Mission Is to Educate Our Community on the Exciting and KEYNOTE SPEAKER Varied Opportunities of Investing in Startup Businesses
To discover and promote opportunities in North Central Washington MAY 4, 2017 WENATCHEE, WASHINGTON www.flywheelconference.com is presented by: ABOUT FLYWHEEL AGENDA 10:00am 2:00pm - 2:50pm PRE-CONFERENCE SEMINAR ON WHAT IS THE DIFFERENCE BETWEEN RAISING CAPITAL FOR STARTUPS VENTURE CAPITAL & PRIVATE EQUITY? presented by Moderated by Chrismon Nofsinger, Nofsinger Group Panelists include: • Aaron Richmond, Endeavour Capital 11:30am • Andy Dale, Montlake Capital, LLC CONFERENCE CHECK-IN OPENS • Erik Benson, Voyager Capital • Todd Marker, Alpine Pacific Capital 12:00pm - 1:00pm • Cole Younger, Arnold Venture Group LUNCHEON AND 3:00pm - 3:50pm The 2017 Flywheel Investment Conference’s mission is to educate our community on the exciting and KEYNOTE SPEAKER varied opportunities of investing in startup businesses. These startups have the potential to bring significant Introductions by Jenny Rojanasthien, COMPANY PRESENTATIONS economic development to our area. Our goal is to create a dynamic, annual event that brings investors, Steve Wright & Shiloh Schauer Moderated by Wiley Kitchell capital resources and startup businesses together. of Moss Adams Capital LLC Presentation by Jonathan Evans Flywheel is directed by Jenny Rojanasthien, Executive Director of GWATA, a 501c3 with a mission to Co-President of Skyward: A Verizon company iFoodDecisionSciences Inc. bring people and technology resources together. Flywheel is also supported by Shiloh Schauer, Executive Diane Wetherington | Founder Director of the Wenatchee Valley Chamber of Commerce. 1:00pm -
RRP Sector Assessment
OrbiMed Asia Partners III, LP Fund (RRP REG 51072) OWNERSHIP, MANAGEMENT, AND GOVERNANCE A. The Fund Structure 1. The Asian Development Bank (ADB) proposes to invest in OrbiMed Asia Partners III, LP Fund (OAP III), which is a Cayman Islands exempted limited partnership seeking to raise up to $500 million in capital commitments. It is managed by OrbiMed Asia GP III, LP (the general partner), a Cayman Islands exempted limited partnership. The sole limited partner of the general partner is OrbiMed Advisors III Limited, a Cayman Islands exempted company. OrbiMed Advisors LLC (the investment advisor), a registered investment advisor with the United States (US) Securities and Exchange Commission, will provide investment advisory services to OAP III. This structure is illustrated in the figure below. Table 1 shows the ultimate beneficial owners (UBOs) of the general partner and the investment advisor. Table 1: Ultimate Beneficial Owners of the General Partner and the Investment Advisor (ownership stake, %) Name Investment Advisor General Partner Sven H. Borho (~10–25%) (~8%) Alexander M. Cooper (~8%) Carl L. Gordon (~10–25%) (~8%) (also Director) Geoffrey C. Hsu (<5%) (~8%) Samuel D. Isaly (~50–75%) (~8%) W. Carter Neild (<5%) (~8%) (also Director) Jonathan T. Silverstein (~5–10%) (~8%) (also Director) Sunny Sharma (~8%) (also Officer) Evan D. Sotiriou (~8%) David G. Wang (~8%) (also Officer) Jonathan Wang (~8%) (also Officer) Sam Block III (~8%) Source: OrbiMed Group. 2 2. Investors. The fund held a first closing of approximately $233.5 million on 1 March 2017, and a second closing of approximately $137.6 million on 26 April 2017. -
Understanding Private Equity. What Is Private Equity? EXAMPLES of PRIVATELY HELD COMPANIES
Understanding private equity. What is private equity? EXAMPLES OF PRIVATELY HELD COMPANIES: A private equity investor is an individual or entity that invests capital into a private company (i.e. firms not traded on a public exchange) in exchange for equity interest in that business. In the US, there are approximately 18,000 publicly traded companies, and more than 300,000 privately held companies. WHO MIGHT SEEK A PRIVATE EQUITY INVESTOR AS A SOURCE OF CAPITAL? • Companies looking to fund a capital need that is beyond traditional bank financing • Owners considering a partial or complete sale of their business • Managers looking to buy a business Private equity strategies. EXAMPLES OF PRIVATE EQUITY FIRMS: MOST PRIVATE EQUITY INVESTORS WILL LIMIT THEIR INVESTMENTS TO ONE OR TWO OF THE FOLLOWING STRATEGIES: • Angel investing • Growth capital • Venture capital • Distressed investments • Leveraged buyouts (LBO) • Mezzanine capital Sources of capital for PE funds. THERE ARE TWO TYPES OF PRIVATE EQUITY FIRMS: • Firms with a dedicated fund, with the majority of the capital sourced from institutional investors (i.e. pension funds, banks, endowments, etc.) and accredited investors (i.e. high net worth individual investors) • Firms that raise capital from investors on a per-deal basis (pledge funds) INVESTMENT DURATION AND RETURNS. • Typical investment period is 3−10 years, after which capital is distributed to investors • Rates of return are higher than public market returns, typically 15−30%, depending on the strategy HISTORICAL S&P 500 RETURNS S&P 500 Returns Average Source: Standard & Poor’s LCD Private equity fund structure. PRIVATE EQUITY FIRM LIMITED PARTNERS (Investors) (Public pension funds, corporate pension funds, insurance companies, high net worth individuals, family offices, endowments, banks, foundations, funds-of-funds, etc.) Management Company General Partner Fund Ownership Fund Investment Management PRIVATE EQUITY FUND (Limited Partnership) Fund’s Ownership of Portfolio Investments Etc. -
Investor Lunch, New York – 3 March 2006
Investor lunch, New York – 3 March 2006 1 3i team Philip Yea Simon Ball Jonathan Russell Michael Queen Jo Taylor Chris Rowlands Group Chief Executive Group Finance Director Managing Partner Managing Partner Managing Partner Head of Group Markets Buyouts Growth Capital Venture Capital Patrick Dunne Anil Ahuja Gustav Bard Graeme Sword Guy Zarzavatdjian Group Communications Managing Director, India Managing Director, Director, Oil and Gas Managing Director, Director Nordic Region France 2 Investor lunch, New York – 3 March 2006 Contents • Introduction to 3i • The private equity market • Interim results to 30 September 2005 • Investor relations • Closing remarks 3 Investor lunch, New York – 3 March 2006 Introduction to 3i 3i at a glance • A world leader in private equity and venture capital • Established 1945; IPO on London Stock Exchange 1994 (IPO at 272p) • Market capitalisation £5.0bn (as at 31 January 2006) • 3i has invested over £15bn in over 14,000 businesses • Portfolio value £4.4bn, in 1,285 businesses (as at 30 September 2005) • Network of teams located in 14 countries in Europe, Asia and the US • 3i also manages and advises third party funds totalling £1.8bn (as at 30 September 2005) • Member of the MSCI Europe, FTSE100, Eurotop 300 and DJ Stoxx indices 4 Investor lunch, New York – 3 March 2006 Introduction to 3i Our Board • Chairman Baroness Hogg • Six independent non-executive directors − Oliver Stocken (Deputy Chairman; Senior Independent Director) − Dr Peter Mihatsch − Christine Morin-Postel − Danny Rosenkranz − Sir Robert Smith -
Corporate Venturing Report 2019
Corporate Venturing 2019 Report SUMMIT@RSM All Rights Reserved. Copyright © 2019. Created by Joshua Eckblad, Academic Researcher at TiSEM in The Netherlands. 2 TABLE OF CONTENTS LEAD AUTHORS 03 Forewords Joshua G. Eckblad 06 All Investors In External Startups [email protected] 21 Corporate VC Investors https://www.corporateventuringresearch.org/ 38 Accelerator Investors CentER PhD Candidate, Department of Management 43 2018 Global Startup Fundraising Survey (Our Results) Tilburg School of Economics and Management (TiSEM) Tilburg University, The Netherlands 56 2019 Global Startup Fundraising Survey (Please Distribute) Dr. Tobias Gutmann [email protected] https://www.corporateventuringresearch.org/ LEGAL DISCLAIMER Post-Doctoral Researcher Dr. Ing. h.c. F. Porsche AG Chair of Strategic Management and Digital Entrepreneurship The information contained herein is for the prospects of specific companies. While HHL Leipzig Graduate School of Management, Germany general guidance on matters of interest, and every attempt has been made to ensure that intended for the personal use of the reader the information contained in this report has only. The analyses and conclusions are been obtained and arranged with due care, Christian Lindener based on publicly available information, Wayra is not responsible for any Pitchbook, CBInsights and information inaccuracies, errors or omissions contained [email protected] provided in the course of recent surveys in or relating to, this information. No Managing Director with a sample of startups and corporate information herein may be replicated Wayra Germany firms. without prior consent by Wayra. Wayra Germany GmbH (“Wayra”) accepts no Wayra Germany GmbH liability for any actions taken as response Kaufingerstraße 15 hereto. -
Caris Life Sciences Raises $830 Million in Growth Equity Capital to Continue to Expand Its Precision Medicine Platform
FOR IMMEDIATE RELEASE Caris Life Sciences Raises $830 Million in Growth Equity Capital to Continue to Expand its Precision Medicine Platform Accelerates Caris’ rapid growth as the market leader reshaping precision oncology through basic science research and the application of artificial intelligence to one of the largest clinico-genomic databases Capital raise represents one of the largest private financings in precision medicine supported by a diverse, high-quality syndicate of leading investors IRVING, Texas, May 11, 2021 – Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence (AI) focused on fulfilling the promise of precision medicine, announced an $830 million growth equity round at a post-money valuation of $7.83 billion. With this investment, Caris has raised approximately $1.3 billion in external financing since 2018. This financing represents one of the largest capital raises in precision medicine and includes a diverse syndicate of leading investors. The round was led by Sixth Street, a leading global investment firm making its third investment in Caris since 2018. Funds and accounts advised by T. Rowe Price Associates, Inc., Silver Lake, Fidelity Management & Research Company LLC, and Coatue were significant participants in the round. Additional investors included Columbia Threadneedle Investments, Canada Pension Plan Investment Board, Millennium Management, Neuberger Berman Funds, Highland Capital Management, Rock Springs Capital, OrbiMed, ClearBridge Investments, Tudor Investment Corporation, Eaton Vance Equity (Morgan Stanley), Pura Vida Investments and First Light Asset Management. All existing investors from the 2020 financing participated in this deal along with a number of new investors. The Caris Molecular Intelligence approach allows oncologists to assess all 22,000 genes in both DNA and RNA, utilizing whole exome sequencing, whole transcriptome sequencing, protein analysis, and proprietary AI models and signatures. -
GREATER SEATTLE TECHNOLOGY ECOSYSTEM Study & Entrepreneur’S Guide (2017)
2017 Seattle Technology Ecosystem Study GREATER SEATTLE TECHNOLOGY ECOSYSTEM Study & Entrepreneur’s Guide (2017) Brent DeCracker (MBA Candidate) R. Joe Ottinger Christian Michelet (MBA Candidate) iInnovate Leadership Network Denis Trapido (Faculty Coordinator) [email protected] UWB school of business January 2018 A collaboration between iInnovate and University of Washington Bothell School of Business 1 2017 Seattle Technology Ecosystem Study ABOUT THE AUTHORS IINNOVATE LEADERSHIP NETWORK UNIVERSITY OF WASHINGTON | BOTHELL Iinnovate Leadership Network is a leadership network and advisory firm for The University of Washington Bothell is a the innovation economy helping leaders rapidly developing UW campus just north innovate, scale up, and renew their of Seattle. Its School of Business focuses companies. Iinnovate’s services include on top quality research, excellence in professionally moderated forum groups, teaching, and community engagement. leadership education, and innovation The School’s undergraduate and MBA | growth | renewal advisory. Iinnovate programs inspire business excellence by was founded by Joe Ottinger a former ensuring that current and future leaders management consultant with Harvard have the skills needed to be successful Business School professor John Kotter, in a constantly changing business world. tech executive, and author. Joe cares UW Bothell is known for providing deeply about transforming companies, a participatory student experience communities, and lives through grounded in hands-on learning, close innovation. He and his company have relationships with faculty as teachers and published the Seattle Tech Ecosystem mentors, and the personalized support Study and Entrepreneur’s Guide for of staff who are dedicated to student the last 3 years providing insights to success. The campus is also distinguished entrepreneurs, investors, and service by its focus on cross-disciplinary research providers. -
Eurazeo Confirms Its Excellent Growth
EURAZEO CONFIRMS ITS EXCELLENT GROWTH MOMENTUM IN THE FIRST QUARTER OF 2021: AUM +21% OVER 12 MONTHS AND REVENUES +20% EXCLUDING TRAVEL AND LEISURE Paris, May 20, 2021 Asset management momentum strengthens at end-March • Assets Under Management (AUM): €22.7bn, +21% over LTM, of which +27% for third party • Third-party fundraising: €785m at end-March and c.€1,200m YTD, versus €283m in Q1 2020 • Management fees: €59m, of which +13% for limited partners (+4% overall1 given balance sheet divestments) • The Group expects further growth in fundraising in 2021 thanks to the strong market attractiveness of its current funds, particularly for small-mid buyout, growth and private debt funds Strong growth in portfolio performance • Portfolio economic revenue2 up +20% in Q1 2021 year-on-year (+15% compared to Q1 2019), excluding the Travel & Leisure segment • 61% increase in revenues of Growth portfolio companies (non-consolidated) • Early recovery prospects in Travel & Leisure (10% of NAV) Sustained investment activity • €1.1bn invested (€0.5bn in Q1 2020), with business flows in buoyant sectors notably tech (Questel, PPRO, Message Bird), consumer tech (UPD, Aroma-Zone) and financial services (Groupe Premium) • A high level of asset divestments expected in 2021-2022, as announced Balance sheet remains robust • NAV per share of €85.5 (not revalued quarterly) • Net cash and cash equivalents of €255m at end-March – confirmed RCF of €1.5bn • Dry powder of €3.7bn Virginie Morgon, Chairwoman of the Executive Board, stated: “This first quarter of 2021 reflects Eurazeo's growth momentum in all aspects of its business. The growth in our fundraising and assets under management, but also the strong rebound in our portfolio activity, the sustained pace of our investments in growth sectors, value-creating exits and our ability to support the major shifts towards a more sustainable economy perfectly illustrate our "Power Better Growth" positioning and its attractiveness. -
Unpacking Private Equity Characteristics and Implications by Asset Class
Unpacking Private Equity Characteristics and Implications by Asset Class www.mccombiegroup.com | +1 (786) 664-8340 Unpacking Private Equity: Characteristics & implications by asset class The term private equity is often treated as a catchall, used interchangeably to describe a broad variety of investments. Such loose use of the phrase fails to capture the range of nuanced business ownership strategies it refers to and risks branding an entire asset class with characteristics and implications that are typically relevant to only a particular sub-category. Recently, this has especially been the case given the outsized global attention placed on the leveraged buyout deals of Bain Capital, a private equity firm founded by Republican U.S. presidential candidate Mitt Romney. In this context, popular discourse has inappropriately attached the label of private equity to a general practice of debt-fueled corporate takeovers that disproportionately focus on cost cutting. In reality, however, private equity refers to an array of investment strategies each with a unique risk-return profile and differing core skillsets for success. This article is intended to help family office executives better understand the nuances of the various sub-categories of private equity. It seeks to draw high-level distinctions, serving as a practical guide for investors entering the private equity arena, be it directly or through a more curated fund structure. Ultimately by understanding the characteristics and implications of each asset class, the reader should be equipped to make an educated choice regarding the most relevant and appropriate strategy for their unique profile. From a technical perspective, private equity is nothing more than making investments into illiquid non-publicly traded companies— i.e. -
20Th Annual Growth Capital Symposium June 19-20, 2001 Ann Arbor, Michigan
20th Annual Growth Capital Symposium June 19-20, 2001 Ann Arbor, Michigan University of Michigan Business School presented by: Center for Venture Capital and Private Equity Finance (CVP) The University of Michigan Business School Dr. David J. Brophy, Director www.umich.edu/~cvpumbs sponsored by: THE 20th ANNUAL GROWTH CAPITAL SYMPOSIUM June 19-20, 2001 In the last five years the venture capital industry has experienced a true "boom-and-bust", with unprecedented growth in capital raised and invested, growth in valuations and deal- flow, mostly centered around the internet. This was followed by a sharp decline in the capital markets and the demand for technology, which was reflected in the performance of the portfolios of many venture capital investors. Beyond the current state of the market, however, there are few significant trends emerging that will mark the path for the next few years in the business. The focus of the 20th Growth Capital Symposium is to bring to the forefront views from the leaders on the investment and technology fronts who have managed to break ahead of the curve and are preparing to take advantage of the general market conditions. This is echoed in the sentiment among a growing group of investors who believe that the next few years will be in fact some of the best for venture capital investment. Tuesday, 19th June The Symposium will begin at 10:00am Tuesday morning in Hale Auditorium in the University of Michigan Business School, and will conclude at 5:30pm with a reception at the Museum of Art and a dinner at the Michigan Union. -
2016 ESG REPORT Being a Customer-Focused Responsible Investor
2016 ESG REPORT Being a customer-focused responsible investor ///////////////////////////////////////////////////////// Contents 05 Editorial 07 Idinvest Partners’ ESG policy : historical perspective and 2015 developments Main action taken in 2015 08 Responsible Private Equity strategy : A strong commitment organized around four operational positions 09 Integrate ESG issues throughout the entire investment lifecycle 10 2015, a turning point on how climate issues are addressed by our public commitments 11 A team dedicated to ESG considerations 12 The main initiatives taken by Idinvest Partners and its portfolio companies in 2015 14 Summary of 2015 activities and key ESG data 16 Growth capital 22 Private debt 29 Private funds Group 38 Idinvest Partners’ corporate social responsibility (CSR) approach (RSE) of Idinvest Partners 46 Interview with Isabelle Combarel, SWEN CAPITAL PARTNERS Editorial ///////////////////////////////////////////////////////////////////////// Dear clients, partners and staff, With over €6 billion under management, Idinvest Partners is a European leader in financing small and medium-sized enterprises. The companies financed by Idinvest Partners have created more than 7,000 jobs over the past three years. Now more than ever, our commitment to these companies brings meaning and growth against a global awakening to the issues of climate change in the wake of the 2015 Climate Change Conference (COP21). As a pioneer in this area, Idinvest is delighted to see the importance given to environmental, social and governance (ESG) considerations in a growing number of financial investors. This is why, once again, we have decided to show the high standards we expect of ourselves by broadening our responsible private equity strategy. We wish to present you with this report on our actions taken in 2015 and early 2016 and progress made on our responsible investment strategy. -
Bloomberg Briefs
Wednesday June 8, 2016 www.bloombergbriefs.com MedMen Seeks $100 Million for Marijuana Investments QUOTED BY AINSLIE CHANDLER, BLOOMBERG BRIEF Medical cannabis management company MedMen is raising its first institutional fund "This is the toughest decision- as it tries to capitalize on investors' interest in legal marijuana enterprises. making environment that I MedMen is trying to raise $100 million for MedMen Opportunity Fund, according to think we have ever been in.... firm founder and Chief Executive Adam Bierman. Yesterday, JPMorgan comes MedMen, founded in 2009, previously acted as a management company for out and they say there is a 36 businesses with medical marijuana licenses. It also invested money from family offices and venture funds in special purpose vehicles where the investors held the cannabis percent chance of a licenses, Bierman said in a May 26 interview. recession. As a CIO or head Existing investors pushed the firm to raise a fund to allow for greater diversification in of private equity, what do you their portfolios, he said. do with that?" “If you are a multi-billion dollar family office or an institutional quality investor, you are — Glenn Youngkin, President and COO of not making one-off investments in the $3 million to $5 million range with single-asset Carlyle Group, at a conference June 7 exposure in a market that is complicated from a regulatory environment,” Bierman said. The Los Angeles-based firm held a first close on the WEEK IN NUMBERS fund in May and hopes to have a final close within six months, Bierman said. $13.5 billion — Extra return MedMen The fund will invest in cannabis-related projects, he Calstrs calculates it earned from its said.